August 29, 2018
TOPIC: Advocacy, Events, Featured News, Get Involved, Industry, Medical, Patients & Members, Press Releases
Posted at August 8, 2018 10:48 am by Christina Jensen
Washington, D.C., August 29, 2018 – The National Organization for Rare Disorders (NORD), the leading independent nonprofit organization representing the 30 million Americans with rare diseases, has announced some of the speakers confirmed for the 2018 NORD Rare Diseases & Orphan Products Breakthrough Summit, to be held October 15-16 in Washington, D.C…. Read More
July 19, 2018
TOPIC: Featured News, Industry, Medical, Patients & Members, Press Releases, Research, Sticky Posts for Homepage
Posted at July 7, 2018 10:17 am by Christina Jensen
Washington, D.C., July 19, 2018—The National Organization for Rare Disorders (NORD) today launched Gene Therapy: Your Questions Answered, a new video from its RareEDU educational program addressing some of the most commonly asked questions from patients and caregivers on the topic. It is available for viewing here.
July 11, 2018
TOPIC: Advocacy, Events, Featured News, Industry, Patients & Members, Research
Posted at July 7, 2018 09:21 am by Christina Jensen
Dr. Scott Gottlieb was sworn in as the 23rd Commissioner of Food and Drug Administration in 2017, and provided a keynote speech at the NORD Rare Summit shortly thereafter. 2018 marks his second year at the Summit, and we look forward to Dr. Gottlieb’s update for the rare disease community.
In addition… Read More
May 21, 2018
TOPIC: Events, Featured News, Get Involved, Industry, Medical, Patients & Members, Research
Posted at May 5, 2018 03:36 pm by Christina Jensen
We are looking forward to bringing all stakeholders in rare diseases together once again for our annual Rare Diseases and Orphan Products Breakthrough Summit. We hope to see you there! Please mark the details below in your calendars and keep an eye out for a registration announcement in early June.
Rare Diseases &… Read More
April 25, 2018
TOPIC: Featured News, Get Involved, Industry, Medical, Patient Stories
Posted at April 4, 2018 01:07 pm by Christina Jensen
Richard Pazdur, M.D. is the Director of the Food and Drug Administration’s Oncology Center of Excellence (OCE), which leverages the combined skills of the FDA’s regulatory scientists and reviewers with expertise in drugs, biologics and devices to expedite the development of novel cancer products. In his role as director of the OCE, Dr. Pazdur is responsible for leading the… Read More